ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
argenx at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
argenx brings 5 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 1717. Its program centres on myositis and Sjögren's disease, including phase 2 data for efgartigimod PH20 SC in active inflammatory myopathy and real-world studies of treatment patterns and the patient journey.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
A biotechnology company developing antibody-based medicines for autoimmune diseases. | Booth Exhibiting at Booth 1717 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Sun Nov 8 10:30am–12:30pm Talk Sun Nov 8 1:30pm–1:45pm Poster Mon Nov 9 10:30am–12:30pm Industry Mon Nov 9 5:30pm–7:30pm Autoimmune Myositis Reframed: New Perspectives on Burden, Biology and Clinical Outcomes Industry Tue Nov 10 5:30pm–7:30pm IIMagine What’s Next in Myositis Care: Integrating Targeted Strategies to Advance Patient Outcomes |
Find decision makers at argenx
Tell us what you sell and we’ll find the people at argenx most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction